Division of Colon & Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, National Yang-Ming University, No 201, Section 2, Shih-Pai Road Taipei, 11217, Taipei, Taiwan.
Int J Colorectal Dis. 2011 Sep;26(9):1135-41. doi: 10.1007/s00384-011-1209-5. Epub 2011 May 3.
Carcinoembryonic antigen (CEA) measurements performed preoperatively and during the early postoperative period were examined prospectively to assess their prognostic value for colorectal cancer (CRC) patients receiving curative surgery.
Between 2000 and 2004, 1,361 patients with CRC who underwent curative surgery at the Taipei Veterans General Hospital were enrolled prospectively. CEA was measured prior to surgery and during the third or fourth postoperative week. The endpoint was length of postoperative disease-free survival, and prognostic importance was determined using the log-rank test and Cox regression hazard model.
Six hundred (44.1%) CRC patients had high CEA concentrations preoperatively, and 188 (13.8%) patients retained high values postoperatively. Within the median follow-up period of 61 (6-108) months, CRC recurred in 313 patients. By univariate analysis TNM staging, tumor differentiation, lymphovascular invasion, preoperative CEA concentration, and postoperative CEA concentration affected the outcome. By multivariate analysis, the prognostic importance of postoperative CEA was retained (95% CI, 1.73-3.01; HR = 2.28) but that of preoperative CEA was lost (95% CI, 0.82-1.33; HR = 1.05). CRC recurred earlier in patients with high postoperative CEA concentrations; metastasis to the liver was common (72.3%) among patients in this group.
Early postoperative CEA concentration is an independent prognostic factor for CRC. Patients with high postoperative CEA values should receive aggressive follow-up examinations for early relapse of CRC, with special attention paid to recurrence at the liver.
前瞻性地检查术前和术后早期的癌胚抗原 (CEA) 测量值,以评估其对接受根治性手术的结直肠癌 (CRC) 患者的预后价值。
2000 年至 2004 年期间,前瞻性地招募了在台北荣民总医院接受根治性手术的 1361 例 CRC 患者。在手术前和术后第 3 或第 4 周测量 CEA。终点是术后无病生存时间,使用对数秩检验和 Cox 回归风险模型确定预后的重要性。
600 例 (44.1%) CRC 患者术前 CEA 浓度高,188 例 (13.8%) 患者术后仍保持高浓度。在中位随访 61 个月(6-108 个月)期间,313 例患者 CRC 复发。单因素分析显示,TNM 分期、肿瘤分化、淋巴血管侵犯、术前 CEA 浓度和术后 CEA 浓度影响结局。多因素分析保留了术后 CEA 的预后重要性(95%CI,1.73-3.01;HR=2.28),但术前 CEA 的预后重要性丧失(95%CI,0.82-1.33;HR=1.05)。术后 CEA 浓度高的患者 CRC 复发较早;该组患者肝转移常见(72.3%)。
术后早期 CEA 浓度是 CRC 的独立预后因素。术后 CEA 值高的患者应接受积极的随访检查,以早期发现 CRC 复发,并特别注意肝脏的复发。